Global Assisted Reproductive Technology Market Expected to Achieve 9.1% CAGR by 2029: Growth Forecast Insights

Use code ONLINE20 to get 20% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.

How Large Will the Assisted Reproductive Technology Market Size By 2025?
The domain of assisted reproductive technology has experienced significant expansion lately, projecting an increase in market valuation from $34.35 billion in the current year, 2024, to an estimated $37.06 billion by 2025, which translates to a compound annual growth rate of 7.9%; this preceding period's upward trajectory is fundamentally linked to escalating infertility prevalence, shifts in societal perspectives, heightened public consciousness regarding the topic, favorable regulatory backing, and the advancing age demographic.

How Big Is the Assisted Reproductive Technology Market Size Expected to Grow by 2029?
Anticipation is high for robust expansion within the sphere of assisted reproductive technology across the ensuing years, projecting a market valuation of a substantial $52.42 billion by the year 2029, driven by a compound annual growth rate (CAGR) registering at 9.1%; this projected upward trajectory is fueled by several converging factors, notably the mounting prevalence of later-in-life pregnancies in women, escalating global desire for same-sex parenthood options, the proliferation of medical tourism related to these procedures, continuous enhancements in healthcare facilities, and ongoing investment in research and development initiatives. Furthermore, this upcoming period is characterized by several significant industry developments, such as the increasing incorporation of artificial intelligence (AI) technologies, the growing popularity of elective egg freezing procedures, a stronger move towards single-embryo transfer (SET) methods, the routine application of preimplantation genetic testing for aneuploidy (PGT-A) alongside general genetic screening, and the continuous emergence of novel techniques aimed at preserving fertility.

View the full report here:
https://www.thebusinessresearchcompany.com/report/assisted-reproductive-technology-global-market-report

Which Key Market Drivers Powering Assisted Reproductive Technology Market Expansion and Growth?
The anticipated increase in infertility occurrences is poised to stimulate expansion within the assisted reproductive technology sector in the foreseeable future. Infertility is characterized by the inability to achieve pregnancy subsequent to twelve months of consistent, unprotected sexual relations, affecting individuals of both sexes, and its diagnosis centers on this failure to conceive, for which assisted reproductive technology (ART) serves as a treatment, encompassing fertility interventions involving both male sperm and female eggs; for example, the World Health Organization (WHO), an international public health entity headquartered in Switzerland, indicated in April 2023 that a significant proportion of the global reproductive-age populace, along with their familial and communal circles, will contend with infertility, with estimations suggesting that approximately one in six adults, equating to about 17.5% of the world's adult population, faces this challenge, thus the escalating prevalence of infertility acts as a primary catalyst for the advancement of the ART market.

Get your free sample here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=5489&type=smp

Which Fast-Growing Trends Are Poised to Disrupt the Assisted Reproductive Technology Market?
Progress in technology represents a significant movement currently gaining traction within the assisted reproductive technology sector, prompting leading firms in this field to concentrate their efforts on engineering technological remedies aimed at solidifying their competitive standing. As an illustration of this trend, in the tenth month of 2022, Alife Health, an American manufacturer of medical devices, introduced the Alife Assist platform; this collection of tools is specifically engineered to transform the in-vitro fertilization (IVF) procedure through the application of intelligence derived from data and artificial intelligence (AI), thereby assisting clinical choices across critical IVF phases and optimizing the workflow within fertility facilities. This novel offering, which incorporates Stim Assist, Embryo Assist, and Insights components, delivers extensive aid to reproductive endocrinologists, embryologists, and administrative personnel at clinics, leading to better adjustments in drug dosages, more precise embryo assessment, and continuous observation of operational effectiveness, the final outcome being an improved journey and higher achievement percentages for patients undergoing IVF treatments.

What Are the Emerging Segments in the Assisted Reproductive Technology Market?
The assisted reproductive technologymarket covered in this report is segmented -

1) By Diagnosis: Ovulation Testing; Hysterosalpingography; Ovarian Reserve Testing; Genetic Testing
2) By Procedure Type: Fresh Non-Donor; Fresh Donor; Frozen Donor; Frozen Non-Donor; Embryo Or Egg Banking
3) By End-User: Hospitals; Fertility Clinics; Other End-Users

Subsegments:
1) By Ovulation Testing: Urine Ovulation Predictor Kits; Saliva Ovulation Test Kits
2) By Hysterosalpingography (HSG): X-ray HSG; Sonohysterography (SHG)
3) By Ovarian Reserve Testing: Follicle Stimulating Hormone (FSH) Testing; Anti-Müllerian Hormone (AMH) Testing; Antral Follicle Count (AFC) via Ultrasound
4) By Genetic Testing: Preimplantation Genetic Testing (PGT); Carrier Screening Tests; Genetic Compatibility Testing

Tailor your insights and customize the full report here:
https://www.thebusinessresearchcompany.com/customise?id=5489&type=smp

Who Are the Global Leaders in the Assisted Reproductive Technology Market?
Major companies operating in the assisted reproductive technology market include Cooper Surgical Inc., Ferring Pharmaceuticals Ltd., Hamilton Thorne Ltd., Merck KGaA, Genea Limited, California Cryobank, European Sperm Bank, OvaScience Inc., Bloom IVF Centre, Vitrolife AB, FUJIFILM Irvine Scientific Inc., Nidacon International AB, Monash IVF Group Ltd., Cook Medical, INVO Bioscience Inc., Thermo Fisher Scientific Inc., Boston Scientific Corporation, Anecova Sa, Carolinas Fertility Institute, Microm Ltd., Inception Sciences Inc., Progyny Inc., Oxford Gene Technology IP Ltd., IVI-RMA Global, Boston IVF, CARE Fertility Group, Virtus Health, Reproductive Medicine Associates of New York, Shady Grove Fertility, CCRM Fertility, New Hope Fertility Center, Houston Fertility Institute, Pacific Fertility Center, RMA of New Jersey, Sher Fertility Institute, IVF Florida, ORM Fertility, HRC Fertility, Arizona Center for Reproductive Endocrinology & Infertility, San Diego Fertility Center, Fertility Centers of Illinois

Which are the Top Profitable Regional Markets for the Assisted Reproductive Technology Industry?
Europe was the largest region in the assisted reproductive technology market in 2024. North America was the second-largest region in assisted reproductive technology market. The regions covered in the assisted reproductive technology market report include Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

Purchase the full report today:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=5489

This Report Supports:
1.Business Leaders & Investors - To identify growth opportunities, assess risks, and guide strategic decisions.
2.Manufacturers & Suppliers - To understand market trends, customer demand, and competitive positioning.
3.Policy Makers & Regulators - To track industry developments and align regulatory frameworks.
4.Consultants & Analysts - To support market entry, expansion strategies, and client advisory work.

Reach out to us:
The Business Research Company: https://www.thebusinessresearchcompany.com/,
Americas +1 310-496-7795,
Europe +44 7882 955267,
Asia & Others +44 7882 955267 & +91 8897263534,
Email us at info@tbrc.info.

Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Learn More About The Business Research Company
With over 17500+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead.Our flagship product, the Global Market Model (GMM), is a premier market intelligence platform delivering comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.